BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23433711)

  • 1. Invariant natural killer T cells are phenotypically and functionally altered in Fabry disease.
    Pereira CS; Azevedo O; Maia ML; Dias AF; Sa-Miranda C; Macedo MF
    Mol Genet Metab; 2013 Apr; 108(4):241-8. PubMed ID: 23433711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme replacement therapy partially prevents invariant Natural Killer T cell deficiency in the Fabry disease mouse model.
    Macedo MF; Quinta R; Pereira CS; Sa Miranda MC
    Mol Genet Metab; 2012 May; 106(1):83-91. PubMed ID: 22425450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Globotriaosylceramide inhibits iNKT-cell activation in a CD1d-dependent manner.
    Pereira CS; Sa-Miranda C; De Libero G; Mori L; Macedo MF
    Eur J Immunol; 2016 Jan; 46(1):147-53. PubMed ID: 26426881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered invariant natural killer T cell subsets and its functions in patients with oral squamous cell carcinoma.
    Singh AK; Shukla NK; Das SN
    Scand J Immunol; 2013 Nov; 78(5):468-77. PubMed ID: 23980793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice.
    Homma T; Kinugawa S; Takahashi M; Sobirin MA; Saito A; Fukushima A; Suga T; Takada S; Kadoguchi T; Masaki Y; Furihata T; Taniguchi M; Nakayama T; Ishimori N; Iwabuchi K; Tsutsui H
    J Mol Cell Cardiol; 2013 Sep; 62():179-88. PubMed ID: 23774048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.
    Oh SJ; Chung DH
    J Immunol; 2011 Jun; 186(12):6815-21. PubMed ID: 21572032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial correction of the alpha-galactosidase A deficiency and reduction of glycolipid storage in Fabry mice using synthetic vectors.
    Przybylska M; Wu IH; Zhao H; Ziegler RJ; Tousignant JD; Desnick RJ; Scheule RK; Cheng SH; Yew NS
    J Gene Med; 2004 Jan; 6(1):85-92. PubMed ID: 14716680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct and overlapping effector functions of expanded human CD4+, CD8α+ and CD4-CD8α- invariant natural killer T cells.
    O'Reilly V; Zeng SG; Bricard G; Atzberger A; Hogan AE; Jackson J; Feighery C; Porcelli SA; Doherty DG
    PLoS One; 2011; 6(12):e28648. PubMed ID: 22174854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model.
    Fujita H; Teng A; Nozawa R; Takamoto-Matsui Y; Katagiri-Matsumura H; Ikezawa Z; Ishii Y
    J Immunol; 2009 Jul; 183(1):254-60. PubMed ID: 19542437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKT Cell Hyporesponsiveness Leads to Unrestrained Accumulation of Marginal Zone B Cells in Hypercholesterolemic Apolipoprotein E-Deficient Mice.
    Soh SY; Faveeuw C; Thiam CH; Khoo LH; Yeo KP; Lim SY; Lim HY; Ng JX; Angeli V
    J Immunol; 2016 Nov; 197(10):3894-3904. PubMed ID: 27798147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles.
    Macho Fernandez E; Chang J; Fontaine J; Bialecki E; Rodriguez F; Werkmeister E; Krieger V; Ehret C; Heurtault B; Fournel S; Frisch B; Betbeder D; Faveeuw C; Trottein F
    Int J Pharm; 2012 Feb; 423(1):45-54. PubMed ID: 21575695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of iNKT Cells Facilitates Liver Repair After Hepatic Ischemia Reperfusion Injury Through Acceleration of Macrophage Polarization.
    Goto T; Ito Y; Satoh M; Nakamoto S; Nishizawa N; Hosono K; Naitoh T; Eshima K; Iwabuchi K; Hiki N; Amano H
    Front Immunol; 2021; 12():754106. PubMed ID: 34691073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A natural protective function of invariant NKT cells in a mouse model of innate-cell-driven lung inflammation.
    Bourgeois EA; Levescot A; Diem S; Chauvineau A; Bergès H; Milpied P; Lehuen A; Damotte D; Gombert JM; Schneider E; Girard JP; Gourdy P; Herbelin A
    Eur J Immunol; 2011 Feb; 41(2):299-305. PubMed ID: 21268000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of marginal zone B lymphocytes in invariant NKT cell activation.
    Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
    J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invariant NKT cells inhibit development of the Th17 lineage.
    Mars LT; Araujo L; Kerschen P; Diem S; Bourgeois E; Van LP; Carrié N; Dy M; Liblau RS; Herbelin A
    Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6238-43. PubMed ID: 19325124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of Invariant Natural Killer T Cells to Skin Wound Healing.
    Tanno H; Kawakami K; Ritsu M; Kanno E; Suzuki A; Kamimatsuno R; Takagi N; Miyasaka T; Ishii K; Imai Y; Maruyama R; Tachi M
    Am J Pathol; 2015 Dec; 185(12):3248-57. PubMed ID: 26468976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production.
    Bourgeois E; Van LP; Samson M; Diem S; Barra A; Roga S; Gombert JM; Schneider E; Dy M; Gourdy P; Girard JP; Herbelin A
    Eur J Immunol; 2009 Apr; 39(4):1046-55. PubMed ID: 19266498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus.
    Kis J; Engelmann P; Farkas K; Richman G; Eck S; Lolley J; Jalahej H; Borowiec M; Kent SC; Treszl A; Orban T
    J Leukoc Biol; 2007 Mar; 81(3):654-62. PubMed ID: 17151140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.
    Bharhani MS; Chiu B; Na KS; Inman RD
    Int Immunol; 2009 Jul; 21(7):859-70. PubMed ID: 19477915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential dendritic cell-mediated activation and functions of invariant NKT-cell subsets in oral cancer.
    Singh AK; Gaur P; Shukla NK; Das SN
    Oral Dis; 2015 Jan; 21(1):e105-13. PubMed ID: 24654917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.